Skip to main content
Order CJC-1295

A curated front page of the CJC-1295 research — the GHRH-analog pharmacology, the DAC-vs-no-DAC half-life split, and the finding that growth-hormone pulsatility survives continuous stimulation, every study laid out as its own card.

Answers with the research limits

What CJC-1295 safety and hormone tests can tell you

This unapproved compound increases how much growth hormone comes from your gland. Short studies leave important questions about safety unanswered. You'll find what is known and where personal claims go beyond the evidence.

See why the two forms differCheck the paper behind an answer
On this page

On this page

What brief trials leave unknown about side effects

CJC-1295 side effects aren't well established by brief human trials. Your kidneys can hold on to extra water and salt under growth hormone's effects. Swelling or weaker action of insulin can follow [13]. Insulin lowers blood sugar, so weaker action can leave your sugar higher.

Studies have linked some cancers with higher levels of the liver's growth-supporting hormone. You still don't know that the compound causes cancer from those links. In 2024, FDA pharmacy advisers raised immune reactions and other safety concerns. The immune system could treat the compound as something to attack, but lasting risks remain untested.

People's reported experiences mostly come from outside controlled trials. Those users gave personal accounts of changes after trying the compound. You don't get the cause of a change established by those accounts. No long-term CJC-1295 study in healthy adults settles those risks for you.

What makes CJC-1295 a changed copy of a hormone

The compound acts like a natural hormone involved in starting release from your gland [2]. Four changed parts slow breakdown of the compound's chain in your body. The added DAC lets the compound travel with a protein through blood for longer [3]. Without that link, the single compound leaves blood sooner, and isn't a blend or muscle-building steroid.

What follows when CJC-1295 reaches the gland

The compound joins receiving spots on cells in your growth gland [2][3]. Growth hormone comes out of those cells, and the liver's growth-supporting hormone rises too. Both hormones stayed higher for days after a DAC shot in healthy adults [3]. The brief spurts continued [1], without showing you that the adults became healthier.

Why short CJC-1295 tests cannot establish years of safety

CJC-1295 has only limited early tests in people and no treatment approval. Like a short drive, those tests can't reveal years of wear. In 2024, FDA advisers warned of a possible immune reaction against the compound. Your long-term safety remains unknown, alongside possible swelling and cancer concerns.

What remains unknown about CJC-1295 peptides

Peptides are short chains of the small parts found in proteins. Human safety studies concern few people over a short time. Swelling can follow growth hormone's effects, as can weaker insulin action in lowering your blood sugar [13]. Cancer concerns and immune reactions raised in 2024 remain unsettled without long-term CJC-1295 tests.

What separates CJC-1295 from muscle-building steroids

CJC-1295 joins receiving spots on the growth gland's cells to start hormone release [2]. A muscle-building steroid behaves like testosterone, the male hormone involved in sex drive and muscle. The two substances work through different hormones in your body. That difference doesn't establish which is safer for you.

Why FDA pharmacy review did not clear CJC-1295 for treatment

CJC-1295 has no FDA approval or approval from other major medicine regulators. In 2024, FDA advisers reviewed the compound for pharmacy-made medicines. They didn't support adding the compound to the list of permitted ingredients. You didn't get an approved treatment from that pharmacy review.

What CJC-1295 swelling and blood-sugar concerns mean for you

Your kidneys may leave extra water and salt in the body under growth hormone's effects. You could have swelling or less response to insulin, which lowers blood sugar [13]. Less response can leave your blood sugar higher. Studies link some cancers with raised levels of the liver's growth-supporting hormone, without settling your risk.

Why feeling better needs more evidence than a CJC-1295 blood test

CJC-1295 caused lasting rises in growth hormone alongside the liver's growth-supporting hormone [3]. Researchers measured those changes in blood, rather than proved health gains. The tests don't predict how you'd feel after using the compound. CJC-1295 lacks treatment approval, and your possible benefit remains unproved.

What growth-hormone findings cannot say about testosterone

Muscle and sex drive depend partly on testosterone, a male sex hormone. CJC-1295 acts through different hormones involved in growth [2]. Published CJC-1295 research hasn't established that testosterone changed directly from the compound. You can't infer whether testosterone rises or falls from growth-hormone tests.

Why a testosterone fall from CJC-1295 remains unproved

CJC-1295 hasn't been shown to lower testosterone, a male hormone important for sex drive and muscle. The compound acts through your growth hormone instead [2]. That difference doesn't rule out every possible effect on testosterone. Your hormone level can't be predicted from these limited studies.

Why safety cannot be ranked against testosterone treatment

Testosterone treatment replaces a male sex hormone important for muscle and sex drive. Doctors provide that treatment for you as regulated medical care. CJC-1295 affects different hormones and lacks approval for treating people. Controlled trials haven't compared their risks, so you can't rank safety from these studies.

What weight-based CJC-1295 amounts do not tell you

Researchers gave shots containing 30, 60, or 90 micrograms per kilogram each person weighed [3][1]. Micrograms measure tiny amounts, and kilograms measure body weight. Trials haven't established the treatment plans passed around among users. Your study amounts page describes experiments without providing a personal dose.

What dried CJC-1295 powder and special lab water mean

Lab reports describe dried powder made by freezing the compound and removing water. The added water contains a substance that slows bacteria, and the mixture is refrigerated. Four changed parts resist breakdown, while DAC links a blood protein for longer action. Little reaches blood when swallowed, and these aren't handling instructions for you.

What CJC-1295 study injection locations leave unanswered

Human studies mainly gave the compound through shots under the skin [3][1]. Earlier work with a related hormone piece used delivery into a vein [7]. Researchers described where they gave substances during those tests. You don't get a safe injection location or technique from that research description.

What CJC-1295 left steady in the men's hormone-release timing

Brief spurts of growth hormone continued in healthy men given CJC-1295. Between spurts, their growth-hormone level stayed higher after the shot. Their liver's growth-supporting hormone was about 45% higher a week later [1]. Neither size nor timing of spurts changed, without establishing your health benefit.

Which CJC-1295 DAC findings concern the longer-lasting form

The DAC link lets CJC-1295 travel through blood with a protein that leaves blood slowly. Healthy adults given this form had growth-hormone rises lasting days [3]. Most human studies concern the linked CJC-1295 form, rather than the shorter form. Your CJC-1295 DAC vs no-DAC comparison explains why those results can't be borrowed.

Why lasting CJC-1295 DAC action leaves dose questions open

Studies gave one shot with 30-90 micrograms per kilogram each person weighed [3]. Micrograms measure tiny amounts, scaled here to the person's weight in kilograms. Researchers followed hormone changes after using the longer-lasting form. Your safe treatment amount and schedule remain unproved by those studies.

What the CJC-1295 ipamorelin pairing aims to change

CJC-1295 and ipamorelin act at different receiving spots on growth-gland cells [8]. Ipamorelin mainly increases growth-hormone release from cells within that gland. You can see why those different actions interest researchers testing compounds together. Your CJC-1295 with ipamorelin page distinguishes the pairing idea from proved health benefits.

What combined hormone-release tests suggest about CJC-1295

Researchers gave people two related types of hormone-releasing substances together [8]. The hormone rise exceeded the separate rises added together. CJC-1295 has lasting action, while ipamorelin reaches a different spot on the growth gland's cells. That explains interest in testing the pair, without establishing treatment benefits for you.

What the CJC-1295 pair still needs to prove about health

People released more growth hormone when researchers combined related hormone-releasing substances [8]. Those studies didn't prove health gains from the CJC-1295/ipamorelin pair in healthy adults. Claims about your fat loss, faster recovery, and slower aging still need evidence. You don't get those benefits established by a quick hormone rise.

What CJC-1295 ipamorelin tests have not set for use

No controlled human trial sets a treatment amount for CJC-1295/ipamorelin. The pairing idea comes from brief tests combining related hormone-releasing substances [8]. Those tests didn't establish how much of this pair is safe. Your treatment plan can't be built from those different experiments.